Risk of colorectal cancer in inflammatory bowel diseases
Inflammatory bowel diseases (IBDs) are chronic problems of gastrointestinal tract (GIT) with
poorly understood aetiology. Patients with any of the two common entities, Crohn's disease …
poorly understood aetiology. Patients with any of the two common entities, Crohn's disease …
Looking at NSAIDs from a historical perspective and their current status in drug repurposing for cancer treatment and prevention
Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most frequently prescribed
drug classes with wide therapeutic applications over the centuries. Starting from the use of …
drug classes with wide therapeutic applications over the centuries. Starting from the use of …
The relatively selective cyclooxygenase-2 inhibitor nimesulide: What's going on?
E Caiazzo, A Ialenti, C Cicala - European Journal of Pharmacology, 2019 - Elsevier
Nimesulide is a relatively selective cyclooxygenase (COX)-2 inhibitor, non-steroidal anti-
inflammatory drug; it has been discovered in 1971 and firstly commercialized in Italy in 1985 …
inflammatory drug; it has been discovered in 1971 and firstly commercialized in Italy in 1985 …
Prostaglandin E2 and receptors: Insight into tumorigenesis, tumor progression, and treatment of hepatocellular carcinoma
C Chen, J Guan, X Gu, Q Chu, H Zhu - Frontiers in Cell and …, 2022 - frontiersin.org
Hepatocellular carcinoma (HCC) is a common primary liver cancer with∼ 750,000 annual
incidence rates globally. PGE2, usually known as a pro-inflammatory cytokine, is over …
incidence rates globally. PGE2, usually known as a pro-inflammatory cytokine, is over …
In silico environmental risk assessment of fate and effects of pharmaceuticals and their TPs generated and treated by coupling tertiary processes in hospital …
A Della-Flora, D Scunderlick, ML Wilde… - … : Water Research & …, 2023 - pubs.rsc.org
The solar photo-Fenton process leads to the formation of transformation products (TPs) that
are new compounds with an unknown chemical, physical, and biological characteristics …
are new compounds with an unknown chemical, physical, and biological characteristics …
Synthesis and different effects of biotinylated PAMAM G3 dendrimer substituted with nimesulide in human normal fibroblasts and squamous carcinoma cells
Ł Uram, A Filipowicz-Rachwał, M Misiorek, A Winiarz… - Biomolecules, 2019 - mdpi.com
Squamous cell carcinoma (SCC) remains a main cause of mortality in patients with neck and
head cancers, with poor prognosis and increased prevalence despite of available therapies …
head cancers, with poor prognosis and increased prevalence despite of available therapies …
Нестероидные противовоспалительные препараты: более 30 лет на пике актуальности
ОА Лесная - Трудный пациент, 2018 - cyberleninka.ru
Нестероидные противовоспалительные препараты (НПВП) являются наиболее часто
применяемыми в реальной клинической практике лекарственными средствами …
применяемыми в реальной клинической практике лекарственными средствами …
[HTML][HTML] Уменьшение гепатотоксичности нимесулида в составе композиции с глицирризинатом натрия, полученной механохимическим способом
ЕС Петрова, НА Жукова, ВИ Евсеенко… - Сибирский научный …, 2023 - cyberleninka.ru
Нимесулид (NIM)-это нестероидное противовоспалительное средство, действующее
специфически в качестве ингибитора циклооксигеназы 2 и широко используемое для …
специфически в качестве ингибитора циклооксигеназы 2 и широко используемое для …
Нимесулид: разнообразие терапевтических перспектив
ГИ ГРИДНЕВА - Эффективная фармакотерапия, 2019 - elibrary.ru
Нимесулид-один из наиболее широко применяемых нестероидных
противовоспалительных препаратов. Большой спектр эффектов и оптимальное …
противовоспалительных препаратов. Большой спектр эффектов и оптимальное …
Nimesulide Inhibits MAPK/COX-2 Pathway, and Prevents Oxidative Stress, Inflammation, and Apoptosis in Testes of Cisplatin-Challenged Rats
The potential testicular protective effect of nimesulide (NSE) was studied in cisplatin (CSP)-
challenged rats. NSE therapy (10 mg/kg/day, po) was applied for 15 days, and a single dose …
challenged rats. NSE therapy (10 mg/kg/day, po) was applied for 15 days, and a single dose …